Page last updated: 2024-09-05

etravirine and Acquired Immune Deficiency Syndrome

etravirine has been researched along with Acquired Immune Deficiency Syndrome in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (14.29)	29.6817
2010's	6 (85.71)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, JY; Kee, MK; Kim, SS; Kwon, OK; Oh, HR; Park, M; Rhee, JE	1
Brogan, AJ; Martin, S; Mauskopf, J; Talbird, SE	1
Hodder, S; Jayaweera, D; Mrus, J; Ryan, R; Witek, J	1
Campbell, TB; Girard, PM; Grinsztejn, B; Hartikainen, J; Nijs, S; Rachline, A; Witek, J	1
Anderson, D; Coate, B; DeLaitsch, L; DeMasi, R; Surles, T	1
Albanese, A; Asmuth, DM; Hayes, T; Knight, TH; Ma, ZM; Mann, S; Melcher, GP; Miller, CJ; Pollard, RB; Troia-Cancio, P; Yotter, T	1
Susman, E	1

Trials

5 trial(s) available for etravirine and Acquired Immune Deficiency Syndrome

Article	Year
Cost-effectiveness of combination therapy with etravirine in treatment-experienced adults with HIV-1 infection. AIDS (London, England), 2012, Jan-28, Volume: 26, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Anti-HIV Agents; Canada; CD4 Lymphocyte Count; Cost-Benefit Analysis; Darunavir; Double-Blind Method; Drug Therapy, Combination; Female; HIV-1; Humans; Male; Markov Chains; Middle Aged; Models, Economic; Nitriles; Pyridazines; Pyrimidines; Quality-Adjusted Life Years; Ritonavir; Sulfonamides; Viral Load; Young Adult	2012
Efficacy and safety outcomes among treatment-experienced women and men treated with etravirine in gender, race and clinical experience. AIDS research and human retroviruses, 2012, Volume: 28, Issue:6 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Darunavir; Drug Resistance, Multiple, Viral; Female; HIV Protease Inhibitors; HIV-1; Humans; Male; Nitriles; North America; Pyridazines; Pyrimidines; Ritonavir; RNA, Viral; Sex Distribution; Sex Factors; Sulfonamides; Treatment Outcome; Viral Load	2012
Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest. HIV medicine, 2012, Volume: 13, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Dizziness; Double-Blind Method; Exanthema; Female; Headache; Humans; Male; Middle Aged; Mood Disorders; Nitriles; Pyridazines; Pyrimidines; Sleep Wake Disorders; Viral Load	2012
Week 96 outcomes of patients with less treatment experience versus more treatment experience receiving etravirine in the DUET trials. Current HIV research, 2012, Volume: 10, Issue:3 Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Female; HIV-1; Humans; Male; Medication Adherence; Middle Aged; Nitriles; Pyridazines; Pyrimidines; Treatment Outcome; Viral Load	2012
Gastrointestinal-associated lymphoid tissue immune reconstitution in a randomized clinical trial of raltegravir versus non-nucleoside reverse transcriptase inhibitor-based regimens. AIDS (London, England), 2012, Aug-24, Volume: 26, Issue:13 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; Endoscopy; Female; Gastrointestinal Tract; Humans; Immune Reconstitution Inflammatory Syndrome; Immunohistochemistry; Lymphocyte Activation; Lymphoid Tissue; Male; Nevirapine; Nitriles; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load	2012

Other Studies

2 other study(ies) available for etravirine and Acquired Immune Deficiency Syndrome

Article	Year
Drug susceptibility to etravirine and darunavir among Human Immunodeficiency Virus Type 1-derived pseudoviruses in treatment-experienced patients with HIV/AIDS in South Korea. Virology journal, 2015, Apr-09, Volume: 12 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Darunavir; Drug Resistance, Viral; gag Gene Products, Human Immunodeficiency Virus; Genotype; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mutation; Nitriles; Phenotype; pol Gene Products, Human Immunodeficiency Virus; Protein Precursors; Pyridazines; Pyrimidines; Recombination, Genetic; Republic of Korea	2015
AIDS 2006 - XVI International Conference. Time to deliver. IDrugs : the investigational drugs journal, 2006, Volume: 9, Issue:10 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; CCR5 Receptor Antagonists; CD4 Antigens; Clinical Trials as Topic; Humans; Nitriles; Organic Chemicals; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium	2006

Article

Year

Drug susceptibility to etravirine and darunavir among Human Immunodeficiency Virus Type 1-derived pseudoviruses in treatment-experienced patients with HIV/AIDS in South Korea.

Virology journal, 2015, Apr-09, Volume: 12

Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Darunavir; Drug Resistance, Viral; gag Gene Products, Human Immunodeficiency Virus; Genotype; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mutation; Nitriles; Phenotype; pol Gene Products, Human Immunodeficiency Virus; Protein Precursors; Pyridazines; Pyrimidines; Recombination, Genetic; Republic of Korea

2015

AIDS 2006 - XVI International Conference. Time to deliver.

IDrugs : the investigational drugs journal, 2006, Volume: 9, Issue:10

Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Anti-Infective Agents; CCR5 Receptor Antagonists; CD4 Antigens; Clinical Trials as Topic; Humans; Nitriles; Organic Chemicals; Pyridazines; Pyrimidines; Pyrrolidinones; Raltegravir Potassium

2006